CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
BLACANDI aims to revolutionize bladder cancer diagnosis by replacing invasive procedures with a non-invasive urine test. This project utilizes a patented filtration device to enhance tumor cell selection and improve detection rates, potentially reducing healthcare costs significantly.
The BLACANDI project aims to dramatically improve the diagnosis and management of bladder cancer patients by substituting a highly invasive and expensive test with a non-invasive and inexpensive test.
Bladder cancer is the 6th most common cancer with an estimated 357,000 new cases worldwide every year, of which 180,000 are European.
This type of cancer has the highest lifetime treatment costs per patient (pp) of all cancers.
This high incidence, coupled with it’s relapsing nature, means that bla…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
